Observational Study on GEP-and Pulm-NET Treated at FPG
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
| Condition(s) | Neuroendocrine Tumors, Gep Net, Pulmonary Neuroendocrine Neoplasm |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value. |
| Who can participate | Inclusion Criteria: * histological diagnosis of gastroenteropancreatic or pulmonary NET * age ≥ 18 years; * radiological evidence of resectable/locally advanced/metastatic disease; * signing of informed consent; * at least one visit following the first oncological visit. Exclusion Criteria: * absence of clinical data that allow adequate definition of survival (primary endpoint of the study); * absence of histological diagnosis; * failure to sign the informed consent. |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Locations | Rome, Italy |
| Start date | 2023-09-15 |
| NCT ID | NCT06402695 |
| Official listing | https://clinicaltrials.gov/study/NCT06402695 |